Apollo Capital Comments on MediPharm Labs’ Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting
MediPharm Labs Board Continues to Obstruct the Appointment and Oversight of an Independent Chair…
0,051€
10,34%
Echtzeit-Aktienkurs Medipharm Labs Corp.
Bid:
Ask:
Nachrichten zur Medipharm Labs Corp. Aktie
Apollo Capital Issues a With Prejudice Offer to MediPharm Labs and Its Board of Directors to Ensure Shareholder Rights Are Protected at the 2025 Annual Meeting
Believes the Board Continues to Take Oppressive Actions Which Fundamentally Disregard the Rights and Interests of Shareholders…
MediPharm Labs Corp. (MEDIF) Q2 2024 Earnings Call Transcript
…
MediPharm Labs Corp. (MEDIF) Q1 2024 Earnings Call Transcript
…
MediPharm Labs Corp. (MEDIF) Q4 2023 Earnings Call Transcript
…
Market Might Still Lack Some Conviction On MediPharm Labs Corp. (TSE:LABS) Even After 31% Share Price Boost
Despite an already strong run, MediPharm Labs Corp. ( TSE:LABS ) shares have been powering on, with a gain of…